Tryp Therapeutics Alpha and Beta Analysis

TRYPFDelisted Stock  USD 0.05  0  6.89%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tryp Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tryp Therapeutics over a specified time horizon. Remember, high Tryp Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tryp Therapeutics' market risk premium analysis include:
Beta
0.58
Alpha
0.87
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Tryp Therapeutics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Tryp Therapeutics did 0.87  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Tryp Therapeutics stock's relative risk over its benchmark. Tryp Therapeutics has a beta of 0.58  . As returns on the market increase, Tryp Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Tryp Therapeutics is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Tryp Therapeutics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tryp Therapeutics market risk premium is the additional return an investor will receive from holding Tryp Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tryp Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tryp Therapeutics' performance over market.
α0.87   β0.58

Tryp Therapeutics Fundamentals Vs Peers

Comparing Tryp Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Tryp Therapeutics' direct or indirect competition across all of the common fundamentals between Tryp Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Tryp Therapeutics or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Tryp Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Tryp Therapeutics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Tryp Therapeutics to competition
FundamentalsTryp TherapeuticsPeer Average
Return On Equity-9.22-0.31
Return On Asset-2.05-0.14
Current Valuation4.17 M16.62 B
Shares Outstanding96.42 M571.82 M
Shares Owned By Insiders47.24 %10.09 %
Shares Owned By Institutions0.04 %39.21 %
Price To Book2.50 X9.51 X

Tryp Therapeutics Opportunities

Tryp Therapeutics Return and Market Media

The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Tryp Therapeutics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tryp or other otcs. Alpha measures the amount that position in Tryp Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tryp Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tryp Therapeutics' short interest history, or implied volatility extrapolated from Tryp Therapeutics options trading.

Build Portfolio with Tryp Therapeutics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in Tryp OTC Stock

If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments